Table of Contents
<< Previous Issue | Sep 2009 (Vol: 2009, Issue: 9) | Next Issue >> |
- Section: Editorial
-
Personalised Medicine – a Step Closer
- Section: Licensing
-
Bayer Signs Global Agreement for Alpharadin with Algeta
- Section: Mergers & Acquisitions
-
P&G Sells Pharma Division to Focus on Consumer Business
-
Ligand Acquires Neurogen and Access to Merck Partnership
-
Another Japanese Co Gets a Foothold in US Market
-
LEO Targets Peplin for Skin Cancer Drug
-
Alcon Enters Biologicals Arena
-
Taisho Buys OTC Assets from Bristol-Myers
-
Qiagen Acquires Molecular Diagnostics Company DxS
- Section: Opinion & Analysis
-
Deal Making Trends in Oncology
- Section: Research & Development
-
Amylin Heads to India for Diabetes Developments
- Section: Technology Access
-
Shire Targets More Rare Diseases with Santaris’ LNA Platform
-
PTC’s Gene Expression Technology Wins Over Roche and Celgene